EP2842570 - COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS [Right-click to bookmark this link] | |||
Former [2015/10] | Compositions and methods for the prevention and treatment of autoimmune conditions | ||
[2017/44] | Status | No opposition filed within time limit Status updated on 12.03.2021 Database last updated on 03.09.2024 | |
Former | The patent has been granted Status updated on 03.04.2020 | ||
Former | Grant of patent is intended Status updated on 22.10.2019 | ||
Former | Examination is in progress Status updated on 25.07.2018 | ||
Former | Grant of patent is intended Status updated on 22.03.2018 | ||
Former | Examination is in progress Status updated on 24.02.2018 | ||
Former | Grant of patent is intended Status updated on 08.10.2017 | ||
Former | Examination is in progress Status updated on 18.04.2017 | Most recent event Tooltip | 14.06.2024 | Lapse of the patent in a contracting state New state(s): TR | published on 17.07.2024 [2024/29] | Applicant(s) | For all designated states UTI Limited Partnership 3655 36 Street NW Calgary, AB T2L 1Y8 / CA | For all designated states The General Hospital Corporation, d/b/a Massachusetts General Hospital 55 Fruit Street Boston, Massachusetts 20114 / US | [2019/47] |
Former [2019/28] | For all designated states UTI Limited Partnership 3655 36 Street NW Calgary, AB T2L 1Y8 / CA | ||
Former [2015/10] | For all designated states Uti Limited Partnership Suite 130 3553 31st Street NW Calgary, Alberta T2L 2K7 / CA | Inventor(s) | 01 /
Santamaria, Pere 6923 Christie Estates Blvd. S.w. Calgary, Alberta T2N 4N1 / CA | 02 /
Moore, Anna 200 Ledgewood Drive Apt. 107 Stoneham, MA 02180 / US | [2015/19] |
Former [2015/10] | 01 /
Santamaria, Pere 6923 Christie Estates Blvd. S.w. Calgary, Alberta T2N 4N1 / CA | ||
02 /
Moore, Anna 460 Methuen Road Dracut, MA 01826 / US | Representative(s) | Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | [N/P] |
Former [2020/19] | Sagittarius IP Marlow International Parkway Marlow, SL7 1YL / GB | ||
Former [2015/10] | Gibson, Mark Sagittarius IP Three Globeside Fieldhouse Lane Marlow, Buckinghamshire SL7 1HZ / GB | Application number, filing date | 14184505.7 | 07.03.2008 | [2015/10] | Priority number, date | US20070893530P | 07.03.2007 Original published format: US 893530 P | [2015/10] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2842570 | Date: | 04.03.2015 | Language: | EN | [2015/10] | Type: | B1 Patent specification | No.: | EP2842570 | Date: | 06.05.2020 | Language: | EN | [2020/19] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 29.01.2015 | Classification | IPC: | A61K39/00, A61K39/385, A61P37/00, A61P37/06, G01N33/564, G01N33/543, G01N33/569, A61K9/50 | [2017/34] | CPC: |
A61K39/0008 (EP,US);
A61K39/385 (EP,US);
A61K47/6923 (EP,US);
A61K47/6929 (EP,US);
A61K9/5094 (US);
A61P1/02 (EP);
A61P1/04 (EP);
A61P1/16 (EP);
A61P11/06 (EP);
A61P15/08 (EP);
A61P17/00 (EP);
A61P17/02 (EP);
A61P17/12 (EP);
A61P17/14 (EP);
A61P19/02 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/28 (EP);
A61P29/00 (EP);
A61P3/10 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P37/06 (EP);
A61P37/08 (EP);
A61P5/00 (EP);
A61P5/14 (EP);
A61P5/18 (EP);
A61P7/06 (EP);
A61P9/04 (EP);
G01N33/54313 (EP,US);
G01N33/564 (EP,US);
G01N33/56972 (EP,US);
A61K2039/55555 (EP,US);
A61K2039/572 (US);
A61K2039/60 (US);
A61K2039/605 (EP,US);
A61K2039/6093 (US);
A61K2039/627 (US);
G01N2333/70539 (EP,US);
G01N2800/042 (EP,US)
(-)
|
Former IPC [2015/10] | A61K39/00, A61K39/385, A61P37/00, A61P37/06, A61K47/48, G01N33/564, G01N33/543 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2015/35] |
Former [2015/10] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR PRÄVENTION UND BEHANDLUNG VON AUTOIMMUNKRANKHEITEN | [2017/34] | English: | COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF AUTOIMMUNE CONDITIONS | [2017/44] | French: | COMPOSITIONS ET PROCEDES POUR LA PREVENTION ET LE TRAITEMENT D'AFFECTIONS AUTO-IMMUNES | [2017/34] |
Former [2015/10] | Zusammensetzungen und Verfahren zur Prävention und Behandlung von Autoimmunkrankheiten | ||
Former [2015/10] | Compositions and methods for the prevention and treatment of autoimmune conditions | ||
Former [2015/10] | Compositions et procédés pour la prévention et le traitement d'affections auto-immunes | Examination procedure | 16.07.2015 | Amendment by applicant (claims and/or description) | 16.07.2015 | Examination requested [2015/35] | 22.10.2015 | Despatch of a communication from the examining division (Time limit: M04) | 24.02.2016 | Reply to a communication from the examining division | 19.05.2016 | Despatch of a communication from the examining division (Time limit: M04) | 16.08.2016 | Reply to a communication from the examining division | 31.03.2017 | Cancellation of oral proceeding that was planned for 10.04.2017 | 04.04.2017 | Despatch of a communication from the examining division (Time limit: M02) | 10.04.2017 | Date of oral proceedings (cancelled) | 25.05.2017 | Reply to a communication from the examining division | 09.10.2017 | Communication of intention to grant the patent | 19.02.2018 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 19.02.2018 | Fee for grant paid | 19.02.2018 | Fee for publishing/printing paid | 21.03.2018 | Communication of intention to grant the patent | 19.07.2018 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 30.10.2019 | Communication of intention to grant the patent | 05.03.2020 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP08731723.6 / EP2131856 | Divisional application(s) | EP17173410.6 / EP3269384 | Opposition(s) | 09.02.2021 | No opposition filed within time limit [2021/15] | Fees paid | Renewal fee | 11.09.2014 | Renewal fee patent year 03 | 11.09.2014 | Renewal fee patent year 04 | 11.09.2014 | Renewal fee patent year 05 | 11.09.2014 | Renewal fee patent year 06 | 11.09.2014 | Renewal fee patent year 07 | 10.03.2015 | Renewal fee patent year 08 | 10.03.2016 | Renewal fee patent year 09 | 10.03.2017 | Renewal fee patent year 10 | 03.04.2018 | Renewal fee patent year 11 | 27.03.2019 | Renewal fee patent year 12 | 27.03.2020 | Renewal fee patent year 13 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 07.03.2008 | AT | 06.05.2020 | CY | 06.05.2020 | CZ | 06.05.2020 | DK | 06.05.2020 | EE | 06.05.2020 | ES | 06.05.2020 | FI | 06.05.2020 | HR | 06.05.2020 | IT | 06.05.2020 | LT | 06.05.2020 | LV | 06.05.2020 | MC | 06.05.2020 | PL | 06.05.2020 | RO | 06.05.2020 | SE | 06.05.2020 | SI | 06.05.2020 | SK | 06.05.2020 | TR | 06.05.2020 | BG | 06.08.2020 | NO | 06.08.2020 | GR | 07.08.2020 | IS | 06.09.2020 | PT | 07.09.2020 | [2024/29] |
Former [2023/27] | HU | 07.03.2008 | |
AT | 06.05.2020 | ||
CY | 06.05.2020 | ||
CZ | 06.05.2020 | ||
DK | 06.05.2020 | ||
EE | 06.05.2020 | ||
ES | 06.05.2020 | ||
FI | 06.05.2020 | ||
HR | 06.05.2020 | ||
IT | 06.05.2020 | ||
LT | 06.05.2020 | ||
LV | 06.05.2020 | ||
MC | 06.05.2020 | ||
PL | 06.05.2020 | ||
RO | 06.05.2020 | ||
SE | 06.05.2020 | ||
SI | 06.05.2020 | ||
SK | 06.05.2020 | ||
BG | 06.08.2020 | ||
NO | 06.08.2020 | ||
GR | 07.08.2020 | ||
IS | 06.09.2020 | ||
PT | 07.09.2020 | ||
Former [2023/24] | AT | 06.05.2020 | |
CY | 06.05.2020 | ||
CZ | 06.05.2020 | ||
DK | 06.05.2020 | ||
EE | 06.05.2020 | ||
ES | 06.05.2020 | ||
FI | 06.05.2020 | ||
HR | 06.05.2020 | ||
IT | 06.05.2020 | ||
LT | 06.05.2020 | ||
LV | 06.05.2020 | ||
MC | 06.05.2020 | ||
PL | 06.05.2020 | ||
RO | 06.05.2020 | ||
SE | 06.05.2020 | ||
SI | 06.05.2020 | ||
SK | 06.05.2020 | ||
BG | 06.08.2020 | ||
NO | 06.08.2020 | ||
GR | 07.08.2020 | ||
IS | 06.09.2020 | ||
PT | 07.09.2020 | ||
Former [2021/45] | AT | 06.05.2020 | |
CZ | 06.05.2020 | ||
DK | 06.05.2020 | ||
EE | 06.05.2020 | ||
ES | 06.05.2020 | ||
FI | 06.05.2020 | ||
HR | 06.05.2020 | ||
IT | 06.05.2020 | ||
LT | 06.05.2020 | ||
LV | 06.05.2020 | ||
MC | 06.05.2020 | ||
PL | 06.05.2020 | ||
RO | 06.05.2020 | ||
SE | 06.05.2020 | ||
SI | 06.05.2020 | ||
SK | 06.05.2020 | ||
BG | 06.08.2020 | ||
NO | 06.08.2020 | ||
GR | 07.08.2020 | ||
IS | 06.09.2020 | ||
PT | 07.09.2020 | ||
Former [2021/24] | AT | 06.05.2020 | |
CZ | 06.05.2020 | ||
DK | 06.05.2020 | ||
EE | 06.05.2020 | ||
ES | 06.05.2020 | ||
FI | 06.05.2020 | ||
HR | 06.05.2020 | ||
IT | 06.05.2020 | ||
LT | 06.05.2020 | ||
LV | 06.05.2020 | ||
PL | 06.05.2020 | ||
RO | 06.05.2020 | ||
SE | 06.05.2020 | ||
SI | 06.05.2020 | ||
SK | 06.05.2020 | ||
BG | 06.08.2020 | ||
NO | 06.08.2020 | ||
GR | 07.08.2020 | ||
IS | 06.09.2020 | ||
PT | 07.09.2020 | ||
Former [2021/10] | AT | 06.05.2020 | |
CZ | 06.05.2020 | ||
DK | 06.05.2020 | ||
EE | 06.05.2020 | ||
ES | 06.05.2020 | ||
FI | 06.05.2020 | ||
HR | 06.05.2020 | ||
IT | 06.05.2020 | ||
LT | 06.05.2020 | ||
LV | 06.05.2020 | ||
PL | 06.05.2020 | ||
RO | 06.05.2020 | ||
SE | 06.05.2020 | ||
SK | 06.05.2020 | ||
BG | 06.08.2020 | ||
NO | 06.08.2020 | ||
GR | 07.08.2020 | ||
IS | 06.09.2020 | ||
PT | 07.09.2020 | ||
Former [2021/09] | AT | 06.05.2020 | |
CZ | 06.05.2020 | ||
DK | 06.05.2020 | ||
EE | 06.05.2020 | ||
ES | 06.05.2020 | ||
FI | 06.05.2020 | ||
HR | 06.05.2020 | ||
IT | 06.05.2020 | ||
LT | 06.05.2020 | ||
LV | 06.05.2020 | ||
RO | 06.05.2020 | ||
SE | 06.05.2020 | ||
BG | 06.08.2020 | ||
NO | 06.08.2020 | ||
GR | 07.08.2020 | ||
IS | 06.09.2020 | ||
PT | 07.09.2020 | ||
Former [2021/08] | DK | 06.05.2020 | |
ES | 06.05.2020 | ||
FI | 06.05.2020 | ||
HR | 06.05.2020 | ||
LT | 06.05.2020 | ||
LV | 06.05.2020 | ||
RO | 06.05.2020 | ||
SE | 06.05.2020 | ||
BG | 06.08.2020 | ||
NO | 06.08.2020 | ||
GR | 07.08.2020 | ||
IS | 06.09.2020 | ||
PT | 07.09.2020 | ||
Former [2021/01] | FI | 06.05.2020 | |
HR | 06.05.2020 | ||
LT | 06.05.2020 | ||
LV | 06.05.2020 | ||
SE | 06.05.2020 | ||
BG | 06.08.2020 | ||
NO | 06.08.2020 | ||
GR | 07.08.2020 | ||
IS | 06.09.2020 | ||
PT | 07.09.2020 | ||
Former [2020/50] | FI | 06.05.2020 | |
HR | 06.05.2020 | ||
LT | 06.05.2020 | ||
LV | 06.05.2020 | ||
SE | 06.05.2020 | ||
NO | 06.08.2020 | ||
GR | 07.08.2020 | ||
IS | 06.09.2020 | ||
PT | 07.09.2020 | ||
Former [2020/48] | FI | 06.05.2020 | |
LT | 06.05.2020 | ||
SE | 06.05.2020 | ||
NO | 06.08.2020 | ||
IS | 06.09.2020 | ||
PT | 07.09.2020 | ||
Former [2020/47] | LT | 06.05.2020 | |
NO | 06.08.2020 | ||
IS | 06.09.2020 | ||
Former [2020/46] | IS | 06.09.2020 | Documents cited: | Search | [I]US2003068363 (CLARK BRIAN R [US], et al) [I] 9-14* the whole document *; | [Y]WO2004078909 (FRAUNHOFER GES FORSCHUNG [DE], et al) [Y] 1-8,15 * claims 115,128 * * page 9, line 24 - page 11, line 24 *; | [YD] - MOORE ANNA ET AL, "Tracking the recruitment of diabetogenic CD8+ T-cells to the pancreas in real time", DIABETES, (200406), vol. 53, no. 6, ISSN 0012-1797, pages 1459 - 1466, XP002499320 [YD] 1-8,15 * the whole document * DOI: http://dx.doi.org/10.2337/diabetes.53.6.1459 | Examination | US2005003431 | by applicant | US4367110 | US4414148 | US4452901 | US4554101 | US4569789 | US4589071 | US4589330 | EP0188256 | US4659839 | US4671958 | US4680338 | US4699784 | US4818542 | US5543391 | US6103379 | US6387498 | US6651655 | US6688494 | US6712997 | US6846474 | US6929675 | US2005202032 | US7060121 | US7186814 | US2007059775 | US7326399 | US7332586 | - AICHELE ET AL., PROC. NATL. ACAD. SCI. USA, (1994), vol. 91, pages 444 - 448 | - AMRANI ET AL., J. IMMUNOLOGY, (2001), vol. 167, pages 655 - 666 | - AMRANI ET AL., NATURE, (2000), vol. 406, pages 739 - 742 | - ANDERSON ET AL., PROC. NATL. ACAD. SCI. USA, (1999), vol. 96, pages 9311 - 9316 | - ANDERTON; WRAITH, EUR. J. IMMUNOL., (1998), vol. 28, pages 1251 - 1261 | - ARDEN ET AL., DIABETES, (1999), vol. 48, pages 531 - 539 | - ATKINSON; MACLAREN, N. ENGL. J. MED., (1994), vol. 331, pages 1428 - 1436 | - ATKINSON; MACLAREN, SCI. AM., (1990), vol. 7, pages 62 - 67 | - BARANY; MERRIFIELD, The Peptides, ACADEMIC PRESS, (1979), pages 1 - 284 | - BIELEKOVA ET AL., NAT. MED., (2000), vol. 6, pages 1167 - 1175 | - BOTTAZZO, N. ENGL. J. MED., (1985), vol. 313, pages 353 - 360 | - BURKE ET AL., J. INF. DIS., (1994), vol. 170, pages 1110 - 1119 | - CAO ET AL., HUM. IMMUNOL., (2001), vol. 62, page 1009 | - CARUSO ET AL., MACROMOLECULES, (1999), vol. 32, no. 7, pages 2317 - 2328 | - CARUSO, J. AMER. CHEM. SOC., (1999), vol. 121, no. 25, pages 6039 - 6046 | - CASTANO; EISENBARTH, ANNU. REV. IMMUNOL., (1990), vol. 8, pages 647 - 679 | - CHENTOUFI; POLYCHRONAKOS, DIABETES, (2002), vol. 51, page 1383 | - CHOU; FASMAN, ADV. ENZYMOL., (1978), vol. 47, pages 45 - 148 | - CHOU; FASMAN, ANNU. REV. BIOCHEM., (1978), vol. 47, pages 251 - 276 | - CHOU; FASMAN, BIOCHEMISTRY, (1974), vol. 13, no. 2, pages 211 - 222 | - CHOU; FASMAN, BIOCHEMISTRY, (1974), vol. 13, no. 2, pages 222 - 245 | - CHOU; FASMAN, BIOPHYS. J., (1979), vol. 26, no. 3, pages 385 - 399 | - DAVIES, ADVANCED MATERIALS, (1998), vol. 10, pages 1264 - 1270 | - DILORENZO, PROC. NATL. ACAD. SCI. USA, (1998), vol. 95, pages 12538 - 12543 | - DOYTCHINOVA ET AL., J. IMMUNOL., (2004), vol. 172, page 4314 | - FENNESSY ET AL., DIABETOLOGIA, (1994), vol. 37, pages 937 - 945 | - GOLMAN; SHINOHARA, TRENDS CHEM. ENGIN., (2000), vol. 6, pages 1 - 6 | - GOULDER ET AL., J. EXP. MED., (2000), vol. 192, pages 1819 - 1832 | - GROUP, D.P.T.-T.D.S, N. ENGL. J. MED., (2002), vol. 346, pages 1685 - 1691 | - HALLER ET AL., N. ENGL. J. MED., (2005), vol. 353, pages 2086 - 2087 | - HAMILTON-WILLIAMS ET AL., PROC. NATL. ACAD. SCI. USA, (2001), vol. 98, page 11533 | - HAN ET AL., J. CLIN. INVEST., (2005), vol. 115, page 1879 | - HAN ET AL., NAT. MED., (2005), vol. 11, pages 645 - 652 | - HANNINEN ET AL., J. CLIN. INVEST., (1992), vol. 90, pages 1901 - 1910 | - HANPRASOPWATTANA, LANGMUIR, (1996), vol. 12, pages 3173 - 3179 | - HONEYMAN ET AL., MOL. MED., (1995), vol. 1, no. 5, pages 576 - 582 | - IMAGAWA ET AL., DIABETES, (2001), vol. 50, pages 1269 - 1273 | - ITOH, J. CLIN. INVEST., (1993), vol. 92, pages 2313 - 2322 | - KAPPOS ET AL., NAT. MED., (2000), vol. 6, pages 1176 - 1182 | - KARIN ET AL., J. EXP. MED., (1994), vol. 180, pages 2227 - 2237 | - KENT ET AL., NATURE, (2005), vol. 435, pages 224 - 228 | - KEYMEULEN ET AL., N. ENGL. J. MED., (2005), vol. 352, no. 25, pages 2598 - 608 | - KREUTER, Colloidal Drug Delivery Systems, MARCEL DEKKER, INC., (1994), pages 219 - 342 | - LIBLAU ET AL., IMMUNITY, (2002), vol. 17, pages 1 - 6 | - LIEBERMAN; DILORENZO, TISSUE ANTIGENS, (2003), vol. 62, pages 359 - 377 | - LIEBERMAN ET AL., J. IMMUNOL., (2004), vol. 173, page 6727 | - LIEBERMAN ET AL., PROC. NATL. ACAD. SCI. USA, (2003), vol. 100, pages 8384 - 8388 | - LIU; WRAITH, INT. IMMUNOL., (1995), vol. 7, pages 1255 - 1263 | - MAREE ET AL., INT. IMMUNOL., (2006), vol. 18, pages 1067 - 1077 | - MARTIN ET AL., J. BIOL. CHEM., (2001), vol. 276, pages 25197 - 25207 | - MCKOWN ET AL., ARTHRITIS RHEUM., (1999), vol. 42, pages 1204 - 1208 | - MERRIFIELD, SCIENCE, (1986), vol. 232, no. 4748, pages 341 - 347 | - METZLER; WRAITH, INT. IMMUNOL., (1993), vol. 5, pages 1159 - 1165 | - MILLER ET AL., J. EXP. MED., (1979), vol. 149, pages 758 - 766 | - MOORE, DIABETES, (2004), vol. 53, pages 1459 - 1466 | - MORIWAKI ET AL., DIABETOLOGIA, (1999), vol. 42, pages 1332 - 1340 | - NAKANISHI ET AL., J. CLIN. ENDOCRINOL. METAB., (1999), vol. 84, pages 3721 - 3725 | - NAKAYAMA ET AL., NATURE, (2005), vol. 435, pages 220 - 224 | - NEJENTSEV ET AL., DIABETES, (1997), vol. 46, pages 1888 - 1895 | - OWERBACH, DIABETES, (2000), vol. 49, pages 508 - 512 | - PALMER ET AL., SCIENCE, (1983), vol. 222, pages 1337 - 1339 | - PARTCH; BROWN, J. ADHESION, (1998), vol. 67, pages 259 - 276 | - PASCOLO ET AL., J. EXP. MED., (1997), vol. 185, page 2043 | - PEKAREK ET AL., NATURE, (1994), vol. 367, page 258 | - PINKSE ET AL., PROC. NATL. ACAD. SCI. USA, (2005), vol. 102, pages 18425 - 18430 | - POCIOT; MCDERMOTT, GENES IMMUN., (2002), vol. 3, pages 235 - 249 | - POZZILLI ET AL., DIABETOLOGIA, (2000), vol. 43, pages 1000 - 1004 | - ROBLES ET AL., CLIN. IMMUNOL., (2002), vol. 102, pages 117 - 224 | - SANTAMARIA ET AL., DIABETES, (1992), vol. 41, pages 53 - 61 | - SANTAMARIA ET AL., J. IMMUNOL., (1995), vol. 154, page 2494 | - SANTAMARIA, CURR. OPIN IMMUNOL., (2001), vol. 13, pages 663 - 669 | - SERREZE ET AL., DIABETES, (1994), vol. 43, page 505 | - SERREZE, DIABETES, (2001), vol. 50, pages 1992 - 2000 | - SIBLEY ET AL., LAB. INVEST., (1985), vol. 53, pages 132 - 144 | - SIDNEY ET AL., HUM. IMMUNOL., (1996), vol. 45, page 79 | - SOMOZA ET AL., J. IMMUNOL., (1994), vol. 153, pages 1360 - 1377 | - SUKHORUKOV ET AL., POLYMERS ADV. TECH., (1998), vol. 9, no. 10-11, pages 759 - 767 | - TAIT, HUM. IMMUNOL., (1995), vol. 42, pages 116 - 124 | - TAKAKI ET AL., J. IMMUNOL., (2006), vol. 176, pages 3257 - 3265 | - TAM ET AL., J. AM. CHEM. SOC., (1983), vol. 105, page 6442 | - TAN ET AL., J. EXP. MED., (2002), vol. 12, pages 1523 - 1532 | - TICE; TABIBI, Treatise on Controlled Drug Delivery, MARCEL DEKKER, INC., (1992), pages 315 - 339 | - TIGGES ET AL., J. IMMUNOL., (1996), vol. 156, no. 10, pages 3901 - 3910 | - TOES ET AL., PROC. NATL. ACAD. SCI. USA, (1996), vol. 93, pages 7855 - 7860 | - TOMA ET AL., PROC. NATL. ACAD. SCI. USA, (2005), vol. 102, pages 10581 - 10585 | - TRENTHAM ET AL., SCIENCE, (1993), vol. 261, pages 1727 - 1730 | - TRUDEAU ET AL., J. CLIN. INVEST., (2003), vol. 111, pages 217 - 223 | - VERDAGUER ET AL., J IMMUNOTOGY, (1996), vol. 157, pages 4726 - 4735 | - VERDAGUER ET AL., J. EXP. MED., (1997), vol. 186, pages 1663 - 1676 | - WEINER, SCIENCE, (1993), vol. 259, pages 1321 - 1324 | - WONG ET AL., NAT. MED., (1999), vol. 5, pages 1026 - 1031 | - WRAITH ET AL., CELL, (1989), vol. 59, pages 247 - 255 | - YEAMAN ET AL., ANN. NYACAD. SCI., (2002), vol. 955, pages 174 - 182 |